Mangoceuticals (Mangoceuticals) ROCE % : 0.00% (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mangoceuticals ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Mangoceuticals's annualized ROCE % for the quarter that ended in Mar. 2024 was 0.00%.

Mangoceuticals ROCE % Historical Data

The historical data trend for Mangoceuticals's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mangoceuticals ROCE % Chart

Mangoceuticals Annual Data

Trend

Dec21

Dec22

Dec23

ROCE %

-548.76

-1,164.60

Mangoceuticals Quarterly Data
	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial					-438.00	-260.71	-317.14	-900.13	-

Mangoceuticals ROCE % Calculation

Mangoceuticals's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	-9.212	/	( ( (1.003 - 0.261)	+	(1.051 - 0.211) )	/ 2 )
	=	-9.212	/	( (0.742	+	0.84)	/ 2 )
	=	-9.212	/	0.791
	=	-1,164.60 %

Mangoceuticals's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	-9.472	/	( ( (1.051 - 0.211)	+	(0.301 - 1.212) )	/ 2 )
	=	-9.472	/	( ( 0.84	+	-0.911 )	/ 2 )
	=	-9.472	/	-0.0355
	=	0 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Mangoceuticals (NAS:MGRX) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Mangoceuticals ROCE % Related Terms

Thank you for viewing the detailed overview of Mangoceuticals's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Mangoceuticals (Mangoceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Mangoceuticals Inc (NAS:MGRX) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

15110 N. Dallas Parkway, Suite 600, Dallas, TX, USA, 75248

Website

https://www.mangoceuticals.com

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The platform provide access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED product.

Executives

Amanda Elizabeth Hammer	officer: Chief Operating Officer	5128 GADSDEN AVENUE, KELLER TX 76244
Jacob D. Cohen	director, 10 percent owner, officer: CEO	2101 GLENDALE DRIVE, PLANO TX 75023
Tiger Cub Trust	10 percent owner	19 RYDDINGTON PL, DALLAS TX 75230
Kenny Myers	director	5101 ADDISON CIRCLE,, UNIT 401,, ADDISON TX 75001
Lorraine Pamela D'alessio	director	8200 WILSHIRE BLVD, BEVERLY HILLS, CALIFORNIA CA 90211
Eugene M Johnston	officer: CFO	PO BOX 669047, CHARLOTTE NC 28266
Jonathan Arango	director, officer: President, COO and Secretary	15110 DALLAS PARKWAY, SUITE 600, DALLAS TX 75248
Alex P. Hamilton	director	26 LOOP ROAD, BEDFORD NY 10506